Open | - |
Close | - |
Volume / Avg. | 0 / 324.939K |
Day Range | - - - |
52 Wk Range | 180.930 - 348.670 |
Market Cap | $9.071B |
P/E Ratio | 101.017 |
Dividend Yield | - |
Exchange | NYSE |
RSI | 44 |
Short Interest | 8.02% |
Days to Cover | 10.16 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Penumbra (NYSE: PEN) through any online brokerage.
Other companies in Penumbra’s space includes: Steris (NYSE:STE), Masimo (NASDAQ:MASI), Koninklijke Philips (NYSE:PHG), Smith & Nephew (NYSE:SNN) and Abbott Laboratories (NYSE:ABT).
The latest price target for Penumbra (NYSE: PEN) was reported by Piper Sandler on Friday, February 23, 2024. The analyst firm set a price target for 290.00 expecting PEN to rise to within 12 months (a possible 23.74% upside). 33 analyst firms have reported ratings in the last year.
The stock price for Penumbra (NYSE: PEN) is $234.36 last updated March 18, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Penumbra.
Penumbra’s Q1 earnings are confirmed for Tuesday, April 30, 2024.
There is no upcoming split for Penumbra.
Penumbra is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NYSE.